Ear Infection Treatment Market Value Projected To Reach US$ 9.6 Billion By 2028 Covering Covid-19 Impact: Acumen Research and Consulting
August 05, 2021 11:10 ET
|
Acumen Research and Consulting
Acumen Research and Consulting, a global provider of market research studies, in a recently published report titled “Ear Infection Treatment Market– Global Industry Analysis, Market Size,...
Otonomy to Report Second Quarter 2019 Financial Results and Provide Corporate Update
July 25, 2019 16:05 ET
|
Otonomy, Inc.
SAN DIEGO, July 25, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced it...
Otonomy to Present at the Raymond James Life Sciences and MedTech Conference
June 12, 2019 08:00 ET
|
Otonomy, Inc.
SAN DIEGO, June 12, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that...
Otonomy to Report Second Quarter 2018 Financial Results and Provide Corporate Update
August 01, 2018 16:05 ET
|
Otonomy, Inc.
SAN DIEGO, Aug. 01, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced it will...
Otonomy Successfully Completes Open-Label Clinical Trial for OTIPRIO® in Patients with History of Otitis Media Requiring Tympanostomy Tubes
September 15, 2016 07:30 ET
|
Otonomy, Inc.
SAN DIEGO, Sept. 15, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
ENT Devices Market size to exceed $24 Billion by 2023: Global Market Insights, Inc.
June 21, 2016 08:30 ET
|
Global Market Insights
Delaware, June 21, 2016 (GLOBE NEWSWIRE) -- ENT Devices Market size is estimated to exceed USD 24 billion by 2023; according to the latest research report from Global Market Insights, Inc....
Otonomy Announces Pricing of Public Offering of Common Stock
January 06, 2016 19:39 ET
|
Otonomy, Inc.
SAN DIEGO, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases...
Studsvik AB (publ): Interim Report, January-June 2002
August 19, 2002 07:18 ET
|
Studsvik
STOCKHOLM, Sweden, Aug. 19, 2002 (PRIMEZONE) -- Studsvik AB (publ):
- Studsvik's net sales increased by 21 per cent to SEK 492.7
million (408.5).
- The result before tax improved considerably...
Interim Report on the Operations of AB Custos for the Period January 1 - June 30, 2002
July 17, 2002 04:55 ET
|
Custos
STOCKHOLM, Sweden, July 17, 2002 (PRIMEZONE) -- AB Custos:
. Total return on Custos shares during the report period was 14
percent, more than 35 percentage points better than the SIX
Return...
Kungsleden AB (publ): Interim Report, January 1- March 31, 2002 (with link)
April 23, 2002 06:42 ET
|
Kungsleden
STOCKHOLM, Sweden, April 23, 2002 (PRIMEZONE) -- Kungsleden AB (publ):
-- Profit before tax was SEK 129 m (74 m), corresponding to
earnings per share of SEK 6.8 (3.9).
-- Kungsleden's...